In this episode, we dive into the potential of liquid biopsies as a method to detect deadly diseases. We speak with three experts – Marta Herreros, Rik Bryan, and Doug Ward – to learn more about the non-invasive nature of liquid biopsies and the process of detecting biomarkers within a patient sample. Rik and Doug discuss their GALEAS Bladder test, which can identify key mutations present in 96% of bladder cancer patients. Tune in to learn more about the potential of liquid biopsies and the importance of early detection!
Transcript

Show notes

GALEAS Bladder test – Galeas Bladder
BBC and hybrid working – Internal Communications Europe 2023 — BBC
Identification by ears – Ear identification: A multi-ethnic study sample - ScienceDirect

Keywords: bladder cancer, patient, liquid biopsy, urine, cells, bladder, urine test, urine sample, mutations, tumor, DNA, cancer, clinical trials, sequencing, samples, biomarkers.

Ver todos los episodios